title: [New approaches to neuro-metabolic pharmacotherapy of discirculatory encephalopathy].
abstract: Modern view on pathogenesis and clinics of one of the most important forms of chronic cerebrovascular insufficiency--discirculatory encephalopathy has been presented in this article. The author has analyzed requirements to optimal treatment choice of this pathology. Action mechanisms and peculiarities of clinical use of Vasonat medication were detailed. This medication with good clinical and pharmacological properties allows to realize the strategy of pathogenetically proved neuromethabolical pharmacotherapy in angioneurology. Clinical advantage of Vasonat, its safety characteristics, and recommendations of practical use have been detailed.
authors.forename: S G
authors.initials: SG
authors.lastname: Burchinskiĭ
mesh_terms: D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D008763:Methylhydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D009474:Neurons / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D008763:Methylhydrazines; D018696:Neuroprotective Agents; C050147:3-(2,2,2-trimethylhydrazine)propionate